Do analysts rate AVNS or SNAL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Snail 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Is AVNS or SNAL more profitable?

Avanos Medical has a net margin of -10.39% compared to Snail's net margin of -11.73%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity. Company Net Margins Return on Equity Return on Assets Avanos Medical -10.39% 5.39% 3.97% Snail -11.73% -15.49% 5.24%

Does the media favor AVNS or SNAL?

In the previous week, Snail had 7 more articles in the media than Avanos Medical. MarketBeat recorded 11 mentions for Snail and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.10 beat Snail's score of 0.54 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Snail 2 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer AVNS or LIVN?

LivaNova has a consensus target price of $83.50, suggesting a potential upside of 11.09%. Given LivaNova's stronger consensus rating and higher possible upside, analysts plainly believe LivaNova is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 LivaNova 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.73

Does the media favor AVNS or LIVN?

In the previous week, LivaNova had 12 more articles in the media than Avanos Medical. MarketBeat recorded 16 mentions for LivaNova and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.10 beat LivaNova's score of 0.92 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 6 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend AVNS or NVST?

Envista has a consensus price target of $29.31, suggesting a potential upside of 3.53%. Given Envista's stronger consensus rating and higher probable upside, analysts plainly believe Envista is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Envista 0 Sell rating(s) 10 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.38

Which has better valuation and earnings, AVNS or NVST?

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avanos Medical $715.90M 1.64 -$72.90M -$1.61 N/A Envista $2.72B 1.69 $47M $0.41 69.05

Does the media favor AVNS or NVST?

In the previous week, Envista had 13 more articles in the media than Avanos Medical. MarketBeat recorded 17 mentions for Envista and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.10 beat Envista's score of 0.72 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 4 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend AVNS or IRTC?

iRhythm Technologies has a consensus target price of $179.36, indicating a potential upside of 39.77%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts clearly believe iRhythm Technologies is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 iRhythm Technologies 1 Sell rating(s) 1 Hold rating(s) 12 Buy rating(s) 2 Strong Buy rating(s) 2.94

Does the media prefer AVNS or IRTC?

In the previous week, iRhythm Technologies had 15 more articles in the media than Avanos Medical. MarketBeat recorded 19 mentions for iRhythm Technologies and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.10 beat iRhythm Technologies' score of 0.94 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 9 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Do analysts recommend ESTA or AVNS?

Establishment Labs currently has a consensus price target of $100.25, suggesting a potential upside of 29.55%. Given Establishment Labs' stronger consensus rating and higher possible upside, equities research analysts clearly believe Establishment Labs is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67 Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to ESTA or AVNS?

In the previous week, Establishment Labs had 11 more articles in the media than Avanos Medical. MarketBeat recorded 15 mentions for Establishment Labs and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.10 beat Establishment Labs' score of 0.05 indicating that Avanos Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 3 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Avanos Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Avanos Medical (AVNS) Competitors

$24.99 0.00 (0.00%)

As of 08/6/2026

Compare

AVNS vs. SNAL, LIVN, NVST, IRTC, and ESTA

Should you buy Avanos Medical stock or one of its competitors? MarketBeat compares Avanos Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avanos Medical include Snail (SNAL), LivaNova (LIVN), Envista (NVST), iRhythm Technologies (IRTC), and Establishment Labs (ESTA).

How does Avanos Medical compare to Snail?

Avanos Medical (NYSE:AVNS) and Snail (NASDAQ:SNAL) are related small-cap companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Snail	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Avanos Medical has a net margin of -10.39% compared to Snail's net margin of -11.73%. Avanos Medical's return on equity of 5.39% beat Snail's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Snail	-11.73%	-15.49%	5.24%

Avanos Medical has a beta of 1.57, suggesting that its stock price is 57% more volatile than the broader market. Comparatively, Snail has a beta of 1.29, suggesting that its stock price is 29% more volatile than the broader market.

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 0.4% of Snail shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by insiders. Comparatively, 66.8% of Snail shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Snail has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Snail, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
Snail	$88.41M	0.46	-$27.24M	-$3.10	N/A

In the previous week, Snail had 7 more articles in the media than Avanos Medical. MarketBeat recorded 11 mentions for Snail and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.10 beat Snail's score of 0.54 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Snail	2 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Avanos Medical and Snail tied by winning 8 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to LivaNova?

Avanos Medical (NYSE:AVNS) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, valuation, dividends, risk and institutional ownership.

LivaNova has a consensus target price of $83.50, suggesting a potential upside of 11.09%. Given LivaNova's stronger consensus rating and higher possible upside, analysts plainly believe LivaNova is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
LivaNova	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

Avanos Medical has higher earnings, but lower revenue than LivaNova. Avanos Medical is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
LivaNova	$1.39B	2.97	-$242.47M	$1.95	38.55

Avanos Medical has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

LivaNova has a net margin of 12.82% compared to Avanos Medical's net margin of -10.39%. LivaNova's return on equity of 16.36% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
LivaNova	12.82%	16.36%	7.76%

In the previous week, LivaNova had 12 more articles in the media than Avanos Medical. MarketBeat recorded 16 mentions for LivaNova and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.10 beat LivaNova's score of 0.92 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LivaNova	6 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 2.3% of Avanos Medical shares are owned by insiders. Comparatively, 0.4% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

LivaNova beats Avanos Medical on 13 of the 17 factors compared between the two stocks.

How does Avanos Medical compare to Envista?

Avanos Medical (NYSE:AVNS) and Envista (NYSE:NVST) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

Envista has higher revenue and earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
Envista	$2.72B	1.69	$47M	$0.41	69.05

95.2% of Avanos Medical shares are held by institutional investors. 2.3% of Avanos Medical shares are held by insiders. Comparatively, 1.0% of Envista shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Avanos Medical has a beta of 1.57, suggesting that its stock price is 57% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

In the previous week, Envista had 13 more articles in the media than Avanos Medical. MarketBeat recorded 17 mentions for Envista and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.10 beat Envista's score of 0.72 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	4 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Envista has a consensus price target of $29.31, suggesting a potential upside of 3.53%. Given Envista's stronger consensus rating and higher probable upside, analysts plainly believe Envista is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

Envista has a net margin of 3.33% compared to Avanos Medical's net margin of -10.39%. Envista's return on equity of 7.87% beat Avanos Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Envista	3.33%	7.87%	4.32%

Summary

Envista beats Avanos Medical on 12 of the 16 factors compared between the two stocks.

How does Avanos Medical compare to iRhythm Technologies?

Avanos Medical (NYSE:AVNS) and iRhythm Technologies (NASDAQ:IRTC) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

95.2% of Avanos Medical shares are held by institutional investors. 2.3% of Avanos Medical shares are held by insiders. Comparatively, 1.0% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, iRhythm Technologies had 15 more articles in the media than Avanos Medical. MarketBeat recorded 19 mentions for iRhythm Technologies and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.10 beat iRhythm Technologies' score of 0.94 indicating that Avanos Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	9 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

iRhythm Technologies has a net margin of -3.53% compared to Avanos Medical's net margin of -10.39%. Avanos Medical's return on equity of 5.39% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
iRhythm Technologies	-3.53%	-10.26%	-1.39%

iRhythm Technologies has higher revenue and earnings than Avanos Medical. iRhythm Technologies is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A
iRhythm Technologies	$747.14M	5.64	-$44.55M	-$0.86	N/A

Avanos Medical has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market.

iRhythm Technologies has a consensus target price of $179.36, indicating a potential upside of 39.77%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts clearly believe iRhythm Technologies is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

Summary

iRhythm Technologies beats Avanos Medical on 10 of the 17 factors compared between the two stocks.

How does Avanos Medical compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and Avanos Medical (NYSE:AVNS) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Establishment Labs currently has a consensus price target of $100.25, suggesting a potential upside of 29.55%. Given Establishment Labs' stronger consensus rating and higher possible upside, equities research analysts clearly believe Establishment Labs is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Establishment Labs has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market. Comparatively, Avanos Medical has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market.

In the previous week, Establishment Labs had 11 more articles in the media than Avanos Medical. MarketBeat recorded 15 mentions for Establishment Labs and 4 mentions for Avanos Medical. Avanos Medical's average media sentiment score of 1.10 beat Establishment Labs' score of 0.05 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Avanos Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Avanos Medical has a net margin of -10.39% compared to Establishment Labs' net margin of -19.05%. Avanos Medical's return on equity of 5.39% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-19.05%	-218.77%	-12.31%
Avanos Medical	-10.39%	5.39%	3.97%

72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 95.2% of Avanos Medical shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by company insiders. Comparatively, 2.3% of Avanos Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Establishment Labs has higher earnings, but lower revenue than Avanos Medical. Establishment Labs is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	10.79	-$51.06M	-$1.49	N/A
Avanos Medical	$715.90M	1.64	-$72.90M	-$1.61	N/A

Summary

Establishment Labs and Avanos Medical tied by winning 8 of the 16 factors compared between the two stocks.

Get Avanos Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVNS vs. The Competition

Export

Metric	Avanos Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.17B	$5.72B	$6.96B	$24.11B
Dividend Yield	N/A	1.78%	2.59%	3.70%
P/E Ratio	-15.52	24.36	270.83	30.42
Price / Sales	1.64	67.13	663.11	12.94
Price / Cash	7.30	32.43	71.89	33.22
Price / Book	1.49	5.67	13.19	6.88
Net Income	-$72.90M	$148.49M	$3.45B	$1.06B
7 Day Performance	N/A	4.19%	4.32%	2.93%
1 Month Performance	0.26%	-0.40%	-1.87%	2.58%
1 Year Performance	133.22%	9.52%	76.76%	20.36%

Avanos Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVNS Avanos Medical	1.3013 of 5 stars	$24.99 flat	N/A	N/A	$1.17B	$715.90M	N/A	2,287	News Coverage Upcoming Earnings
SNAL Snail	2.6184 of 5 stars	$5.11 +3.2%	N/A	-10.7%	$42.94M	$81.23M	N/A	60
LIVN LivaNova	3.2799 of 5 stars	$82.07 +1.8%	$81.38 -0.8%	+60.0%	$4.51B	$1.43B	42.09	3,300	Positive News Earnings Report Analyst Forecast
NVST Envista	2.4912 of 5 stars	$27.03 +1.4%	$28.54 +5.6%	+39.1%	$4.40B	$2.81B	65.98	12,000	News Coverage Positive News Earnings Report Analyst Forecast
IRTC iRhythm Technologies	4.3638 of 5 stars	$115.22 +2.7%	$184.71 +60.3%	-17.9%	$3.78B	$747.14M	N/A	2,400	Trending News Earnings Report Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AVNS) was last updated on 8/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, LIVN, NVST, IRTC, and ESTA

How does Avanos Medical compare to Snail?

Summary

How does Avanos Medical compare to LivaNova?

Summary

How does Avanos Medical compare to Envista?

Summary

How does Avanos Medical compare to iRhythm Technologies?

Summary

How does Avanos Medical compare to Establishment Labs?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avanos Medical (AVNS) Competitors

AVNS vs. SNAL, LIVN, NVST, IRTC, and ESTA

How does Avanos Medical compare to Snail?

Do analysts rate AVNS or SNAL?

Is AVNS or SNAL more profitable?

Which has more risk & volatility, AVNS or SNAL?

Do insiders & institutionals believe in AVNS or SNAL?

Which has preferable earnings & valuation, AVNS or SNAL?

Does the media favor AVNS or SNAL?

Summary

How does Avanos Medical compare to LivaNova?

Do analysts prefer AVNS or LIVN?

Which has higher earnings & valuation, AVNS or LIVN?

Which has more volatility and risk, AVNS or LIVN?

Is AVNS or LIVN more profitable?

Does the media favor AVNS or LIVN?

Do insiders and institutionals have more ownership in AVNS or LIVN?

Summary

How does Avanos Medical compare to Envista?

Which has better valuation and earnings, AVNS or NVST?

Do insiders and institutionals hold more shares of AVNS or NVST?

Which has more volatility & risk, AVNS or NVST?

Does the media favor AVNS or NVST?

Do analysts recommend AVNS or NVST?

Is AVNS or NVST more profitable?

Summary

How does Avanos Medical compare to iRhythm Technologies?

Do insiders and institutionals believe in AVNS or IRTC?

Does the media prefer AVNS or IRTC?

Is AVNS or IRTC more profitable?

Which has preferable valuation and earnings, AVNS or IRTC?

Which has more risk & volatility, AVNS or IRTC?

Do analysts recommend AVNS or IRTC?

Summary

How does Avanos Medical compare to Establishment Labs?

Do analysts recommend ESTA or AVNS?

Which has more risk and volatility, ESTA or AVNS?

Does the media refer more to ESTA or AVNS?

Is ESTA or AVNS more profitable?

Do insiders and institutionals hold more shares of ESTA or AVNS?

Which has higher earnings and valuation, ESTA or AVNS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVNS vs. The Competition

Avanos Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools